[Table_Author] 分析师 张金洋 | 执业证书： S0590525120012 | | | --- | --- | | 邮箱： | zhangjinyang@glms.com.cn | | 分析师 | 胡偌碧 | | 执业证书： S0590525120011 | | | 邮箱： | huruobi@glms.com.cn | | 分析师 | 乐妍希 | | 执业证书： S0590525110075 | | | 邮箱： | yueyanxi@glms.com.cn | 相对走势 -10% 3% 17% 30% 2025/4 2025/9 2026/3 医药 沪深300 医药周报 20260329 创新药筑底反攻思路&兼论长护险 glmszqdatemark 医药行情回顾&分析&近期判断 2026 年 03 月 29 日 推荐 维持评级 相关研究 本公司具备证券投资咨询业务资格，请务必阅读最后一页免责声明 证券研究报告 1 1）行情回顾：当周（03.23-03.27）医药生物指数环比+1.56%，跑赢创业板指数和沪深 300 指数。在所 有行业中，当周（03.23-03.27）医药涨跌幅排在第 4 位 ...

新里程健康科技集团股份有限公司 证券简称：新里程 证券代码：002219 公告编号：2026-022 新里程健康科技集团股份有限公司 关于为下属医院提供担保的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、担保情况概述 新里程健康科技集团股份有限公司（以下简称"新里程"或"公司"）于 2025 年 4 月 28 日召开第六届董事会第三十三次会议，2025 年 5 月 19 日召开 2024 年 年度股东大会，审议通过了《关于为子公司提供担保额度预计的议案》，同意公 司为相关子公司未来 12 个月向相关合作银行等金融机构申请综合授信额度提供 连带责任担保，额度总计为人民币 181,400 万元（具体内容详见公司于 2025 年 4 月 29 日在巨潮资讯网上披露的《关于为子公司提供担保额度预计的公告》，公 告编号：2025-018）。 近日，公司与广发银行股份有限公司郑州金水路支行（以下简称"广发银行 郑州金水路支行"）签署了《最高额保证合同》，公司为兰考第一医院有限公司（以 下简称"兰考第一医院"）向广发银行郑州金水路支行申请综合授信最高债权额 人民 ...

新里程健康科技集团股份有限公司 证券简称：新里程 证券代码：002219 公告编号：2026-021 新里程健康科技集团股份有限公司 关于全资子公司为二级控股子公司提供担保的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、担保情况概述 近日，新里程健康科技集团股份有限公司（以下简称"新里程"或"公司"） 全资子公司康县独一味生物制药有限公司（以下简称"独一味制药"）与兰州银 行股份有限公司陇南武都支行（以下简称"兰州银行武都支行"）签署了《连带 责任保证合同》，独一味制药为甘肃佛仁制药科技有限公司（以下简称"佛仁制 药"）向兰州银行武都支行申请流动资金借款提供连带责任保证，担保额度为人 民币 4,400 万元。 二、担保审议情况 上述担保为全资子公司对公司合并报表范围内的二级控股子公司提供担保， 独一味制药履行了内部决策程序，佛仁制药其他股东曹明月同时提供了相应的担 保。根据《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范 运作》的相关规定，无需提交公司董事会和股东会审议。 名称：甘肃佛仁制药科技有限公司 成立日期：2004年3月29日 ...

新里程健康科技集团股份有限公司 证券简称：新里程 证券代码：002219 公告编号：2026-020 新里程健康科技集团股份有限公司 关于为全资子公司及子公司为下级子公司提供担保的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、担保情况概述 （一）为全资子公司提供担保的进展情况 新里程健康科技集团股份有限公司（以下简称"新里程"或"公司"）于 2025 年 4 月 28 日召开第六届董事会第三十三次会议，2025 年 5 月 19 日召开 2024 年年度股东大会，审议通过了《关于为子公司提供担保额度预计的议案》，同意 公司为相关子公司未来 12 个月向相关合作银行等金融机构申请综合授信额度提 供连带责任担保，额度总计为人民币 181,400 万元（具体内容详见公司于 2025 年 4 月 29 日在巨潮资讯网上披露的《关于为子公司提供担保额度预计的公告》， 公告编号：2025-018）。 鉴于前期公司与上海浦东发展银行股份有限公司兰州分行（以下简称"浦发 银行兰州分行"）签署的《最高额保证合同》即将到期，公司于近日与浦发银行 兰州分行续签了《最高额 ...

Group 1 - The core point of the article is that New Mile Health Technology Group Co., Ltd. plans to increase the registered capital of its wholly-owned subsidiary, Beijing New Mile Intelligent Robot Co., Ltd., by 100 million yuan, raising its registered capital to 200 million yuan [1] - New Mile Intelligent Robot Co., Ltd. was established on February 9, 2026, and its business scope includes research and sales of intelligent robots, development of artificial intelligence-related software, system integration services, and rehabilitation aid adaptation services [1] - New Mile Health Group has developed a comprehensive health industry structure over the past 10 years, managing over 40 secondary hospitals across nearly 20 provinces in China, with a total of more than 30,000 medical and health care beds [1] Group 2 - The next decade for New Mile Health Group will focus on a new development philosophy of "market-oriented, technology-driven, and globalization," aiming to create a high-quality development standard of "profit + market value" [2] - The company plans to leverage the advantages of medical institutions to promote the integration of medical services with pharmaceuticals, robotics, and insurance, with New Mile Intelligent Robot Co., Ltd. being a key part of this strategy [2] - The company aims to enhance its competitiveness by entering the intelligent robotics sector, which has broad application prospects in medical, nursing, rehabilitation, and elderly care scenarios, thereby creating new business growth points [2]

Core Viewpoint - The company has approved a capital increase for its wholly-owned subsidiary, Beijing New Mileage Intelligent Robot Co., Ltd., to support its strategic development and operational needs, with the aim of enhancing long-term growth and corporate benefits [3][13]. Group 1: Board Meeting Overview - The seventh board meeting was held on February 27, 2026, with all 11 directors present, and the resolutions made were in compliance with relevant laws and the company's articles of association [1][2]. - The board unanimously approved the proposal to increase the registered capital of the subsidiary by 100 million yuan, raising its total registered capital to 200 million yuan [3][5]. Group 2: Capital Increase Details - The capital increase is intended to support the subsidiary's future operations in the fields of medical, nursing, rehabilitation, and elderly care intelligent robotics, aligning with the company's strategic planning [3][15]. - The funding for this capital increase will come from the company's own funds, which amounted to approximately 307.82 million yuan as of September 30, 2025, and the plan is to gradually invest this amount over three years [13][15]. Group 3: Appointment of Vice President - The board has approved the appointment of Mr. Guan Hengye as the Vice President of the company, effective from the date of the board's approval until the end of the current board's term [7][21]. - Mr. Guan has a background in law and has held various positions, including Vice President of New Mileage Health Group, and currently holds 1 million shares in the company, representing 0.03% of total shares [21][22].

Core Viewpoint - New Mile Health Technology Group Co., Ltd. announced the appointment of Mr. Guan Hengye as Vice President, reflecting the company's strategic development needs [2] Group 1 - The seventh board of directors' fifth meeting was held on February 27, 2026, where the appointment was approved [2] - Mr. Guan Hengye is currently a director and vice president of the company and holds 1 million shares, representing 0.03% of the company's total shares [2]

Group 1 - The company announced the appointment of Mr. Guan Hengye as Vice President, approved by the board of directors based on the nomination by Chairman Lin Yanglin, to meet the company's development needs [1] Group 2 - A significant shift has occurred in the AI sector, with China's AI usage surpassing that of the United States for the first time, leading to a surge in various sectors in the A-share market [1] - A well-known Wall Street analyst noted that China's computing power path is overturning traditional perceptions [1]

Group 1 - The company has increased the registered capital of its wholly-owned subsidiary, Beijing New Mileage Intelligent Robot Co., Ltd., by 100 million yuan, raising the registered capital from 100 million yuan to 200 million yuan [1] - The company retains 100% ownership of the subsidiary after the capital increase [1] - Beijing New Mileage Intelligent Robot Co., Ltd. was established on February 9, 2026, and has not yet commenced substantive business operations [1]

新里程健康科技集团股份有限公司 证券简称：新里程 证券代码：002219 公告编号：2026-019 新里程健康科技集团股份有限公司 关于聘任公司副总裁的公告 经核查，截至本公告披露日，关恒业先生持有公司 100 万股股份，持股比例 为 0.03%，系北京新里程健康产业集团有限公司董事，与公司其他董事、高级管 理人员不存在关联关系，不存在受到中国证监会及其他有关部门的处罚和证券交 易所纪律处分的情形，不存在涉嫌犯罪被司法机关立案侦查或涉嫌违法违规被中 国证监会立案调查，尚未有明确结论的情形，不存在《深圳证券交易所上市公司 自律监管指引第 1 号—主板上市公司规范运作》规定的不得担任高级管理人员的 情形。经核实，关恒业先生未被中国证监会在证券期货市场违法失信信息公开查 询平台公示或者被人民法院纳入失信被执行人名单，符合有关法律、行政法规、 部门规章、规范性文件、《深圳证券交易所股票上市规则》《公司章程》及交易所 其他相关规定等要求的任职资格。 特此公告。 1 新里程健康科技集团股份有限公司 新里程健康科技集团股份有限公司 特别提示： 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述 ...